Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
25.76
+2.67 (11.56%)
At close: Mar 9, 2026, 4:00 PM EDT
24.76
-1.00 (-3.88%)
After-hours: Mar 9, 2026, 7:48 PM EDT
Greenwich LifeSciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 357 | 148 | 135 | 195 | 319 | 463 | |
| Market Cap Growth | 127.21% | 9.21% | -30.79% | -38.84% | -31.08% | - | |
| Enterprise Value | 353 | 142 | 126 | 180 | 290 | 458 | |
| Last Close Price | 25.76 | 11.23 | 10.52 | 15.20 | 24.33 | 36.47 | |
| PB Ratio | 162.63 | 58.25 | 20.17 | 14.78 | 11.90 | 16.77 | |
| P/TBV Ratio | 163.34 | 58.29 | 20.19 | 14.79 | 11.91 | 16.78 | |
| Debt / Equity Ratio | - | - | - | - | - | 0.01 | |
| Net Debt / Equity Ratio | -1.74 | -1.61 | -1.04 | -1.02 | -1.01 | -1.03 | |
| Net Debt / EBITDA Ratio | 0.19 | 0.26 | 0.75 | 1.68 | 5.92 | 15.26 | |
| Quick Ratio | 2.35 | 2.62 | 23.74 | 51.23 | 70.63 | 27.41 | |
| Current Ratio | 2.35 | 2.62 | 23.74 | 51.23 | 70.63 | 27.41 | |
| Return on Equity (ROE) | -543.43% | -341.95% | -89.30% | -39.08% | -16.78% | -14.18% | |
| Return on Assets (ROA) | -254.19% | -180.50% | -56.95% | -24.70% | -10.28% | -8.12% | |
| Return on Capital Employed (ROCE) | -896.40% | -631.90% | -139.20% | -60.80% | -17.10% | -6.70% | |
| Earnings Yield | -5.46% | -10.70% | -6.58% | -4.01% | -1.43% | -0.40% | |
| Buyback Yield / Dilution | -3.05% | -1.29% | 0.51% | 0.23% | -36.27% | -320.69% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.